• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Live viral vaccines safe for pediatric solid organ transplant recipients

byDonika YakoubandAlex Chan
October 17, 2023
in Chronic Disease, Pediatrics, Public Health, Surgery
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. This cohort study of pediatric solid organ transplant (SOT) patients found that the measles-mumps-rubella (MMR) and varicella-zoster virus (VZV) vaccines were both safe and efficacious, with low risk for serious adverse events and infection. 

Evidence Rating Level: 2 (Good)

In SOT recipients, no recommendation to date has supported the use of live vaccines (MMR and VZV) due to theoretical risk of infection. This immunocompromised population, particularly the pediatric subgroup, is left susceptible to these life-threatening conditions and faces unique challenges in safeguarding their own health. With the rising rates of measles, mumps, and varicella worldwide, there is a role for determining whether these vaccines are able to provide robust protection without compromising safety in this vulnerable group. The current cohort study sought to explore this very topic. A total of 281 kidney or liver transplant patients (270 liver, 9 kidney, 2 liver-kidney recipients) who had not fully completed their MMR and VZV vaccine series and/or displayed nonprotective serum antibodies were selected. Most patients were receiving low level immunosuppression (although some were receiving more extensive immunosuppression), were more than 1 year post transplant and two months post rejection, and were assessed to have age-appropriate lymphocyte counts. Patients received between 1-3 doses of MMR, VZV, or both vaccines. In posttransplant participants, when tested for protective antibodies between one to three months post-vaccination, 72% developed protective antibodies for VZV, 86% developed protective antibodies for measles, and 99% developed protective antibodies for mumps. One-year post-vaccination, protective antibodies were maintained in the majority of recipients. Following VZV vaccination, 5 of the 217 children (2%; all receiving moderate to high immunosuppression at the time) developed clinical varicella more than one-week post-vaccine, all with resolution within 1 week (three of the five required antiviral therapy). No measles or rubella cases were recorded, and although one patient experienced transient nontender subauricular lymph node swelling without other symptoms 3 weeks after MMR vaccination, this resolved without intervention. With respect to safety, there were no serious adverse events recorded. The results above indicate that, in this study, live vaccinations post-transplant were both safe and immunogenic. While these preliminary results are promising and could signal a shift in recommendations for live vaccination in this population, further studies should be repeated and elucidate the associations between pretransplant antibody levels/vaccination and findings post-transplant. Other types of organ transplant should also be considered in future studies.

Click to read the study in JAMA Network Open

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

Tags: immunologypediatricstransplantvaccinations
Previous Post

Intraventricular lavage associated with higher risk of serious adverse events

Next Post

The Scan by 2 Minute Medicine®: The Crisis in Gaza, Abortion, Pregnancy and Infant Loss and More, ADHD and Dementia, is there a Link? 

RelatedReports

Newborn health collage: a pair of knitted baby booties on a folded blanket below a teal paper heart
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Childhood illness and sleep collage: a girl asleep under a quilt with a teddy bear, a medicine bottle and a night-light
Pediatrics

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

August 14, 2026
Child health collage: a smiling girl with hair puffs, an open lunchbox with a sandwich, carrots and grapes, and a sneaker
Chronic Disease

The association between parental and offspring body mass index may be due to genetic confounding

June 30, 2026
Psoriatic arthritis collage: an engraved joint glowing teal between two bone ends, folded knit gloves and a jar of cream
Chronic Disease

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis

June 5, 2026
Next Post
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: The Crisis in Gaza, Abortion, Pregnancy and Infant Loss and More, ADHD and Dementia, is there a Link? 

#VisualAbstract: Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

#VisualAbstract: Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

Multicancer early detection blood tests show promise but warrant further clinical evaluation

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Medicaid-reimbursed weight-loss GLP-1 prescriptions fell after coverage withdrawal in 4 states
  • Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults
  • Gait analysis predicts health, sleep, and medication use across 18 body systems
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.